Thomas L Patterson
Overview
Explore the profile of Thomas L Patterson including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
405
Citations
11034
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Shayegi-Nik S, Honer W, Vila-Rodriguez F, Nanditha N, Patterson T, Guillemi S, et al.
BMJ Public Health
. 2025 Feb;
2(1):e000627.
PMID: 40018107
Introduction: Dementia is a progressive and debilitating disease, and people living with HIV (PLWH) often develop dementia much earlier than those not living with HIV. We estimated the incidence and...
2.
Bailey K, Abramovitz D, Rangel G, Harvey-Vera A, Vera C, Patterson T, et al.
AIDS Behav
. 2024 Jul;
28(11):3629-3642.
PMID: 39060837
Safe injection self-efficacy (SISE) is negatively associated with injection risk behaviors among people who inject drugs (PWID) but has not been examined in differing risk environments. We compared responses to...
3.
Kennedy R, Bouck Z, Werb D, Kurmanalieva A, Blyum A, Shumskaya N, et al.
J Int AIDS Soc
. 2024 Jul;
27(7):e26247.
PMID: 38978392
Introduction: Despite the increasing availability of new psychoactive substances (hereafter referred to as "salts") in Eastern Europe and Central Asia, there is a dearth of epidemiological data on the relationship...
4.
Bailey K, Abramovitz D, Rangel G, Harvey-Vera A, Vera C, Patterson T, et al.
medRxiv
. 2024 Jun;
PMID: 38826285
Background: Safe injection self-efficacy (SISE) is negatively associated with injection risk behaviors among people who inject drugs (PWID) but has not been examined in differing risk environments. We compared responses...
5.
Pitpitan E, Horvath K, Aldous J, Stockman J, Patterson T, Liang M, et al.
Trials
. 2024 Mar;
25(1):212.
PMID: 38520030
Background: Significant disparities continue to exist in the HIV care continuum, whereby Hispanic and Black people living with HIV (PLWH) are less likely to achieve viral suppression compared to their...
6.
Wiginton J, Booth R, Smith L, Shakya S, Espinosa da Silva C, Patterson T, et al.
Harm Reduct J
. 2023 Nov;
20(1):165.
PMID: 37940947
Background: Women who inject drugs in Ukraine are disproportionately burdened by HIV. To help address the needs of this population, a greater understanding of how interventions may uniquely benefit women...
7.
Strathdee S, Abramovitz D, Harvey-Vera A, Stamos-Buesig T, Vera C, Artamonova I, et al.
Open Forum Infect Dis
. 2023 Aug;
10(8):ofad392.
PMID: 37547856
Background: We evaluated the impact of a brief peer-led intervention on COVID-19 vaccination among people who inject drugs (PWID) presenting at syringe services program (SSP) locations in San Diego County,...
8.
Algarin A, Werb D, Shumskaya N, Kurmanalieva A, Blyum A, Cepeda J, et al.
AIDS Behav
. 2023 Jul;
28(1):310-319.
PMID: 37523049
The Family Resource Scale (FRS) is a three-factor financial vulnerability (FV) measure. FV may impact HIV transmission risks. Cross-sectional data from 279 people who inject drugs (PWID) in Kyrgyzstan surveyed...
9.
Bailey K, Abramovitz D, Artamonova I, Davidson P, Stamos-Buesig T, Vera C, et al.
Int J Drug Policy
. 2023 Jun;
118:104086.
PMID: 37295217
Background: In North America, overdose rates have steeply risen over the past five years, largely due to the ubiquity of illicitly manufactured fentanyls in the drug supply. Drug checking services...
10.
Subedi S, Nanditha N, Tafessu H, Nathani H, St-Jean M, Elefante J, et al.
BMJ Open
. 2023 Apr;
13(4):e070680.
PMID: 37076145
Objectives: Non-adherence to antipsychotics is the greatest obstacle to treating schizophrenia. We assessed the economic and clinical impacts of adherence to antipsychotics among people living with HIV/AIDS (PLWH) and schizophrenia...